article thumbnail

Smaller Pharmacies, Bigger Impact: Inside Manufacturers’ Specialty Networks in 2025

Drug Channels

Last week, we examined the growing concentration of specialty drug dispensing revenues among the largest pharmacies. See The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market. Today, we dive deeper. Drawing from DCIs new 2025 Economic Report on U.S.

article thumbnail

Transforming Specialty Pharmacy Engagement

Pharmaceutical Commerce

A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Join me in May at Asembia’s 2022 Specialty Pharmacy Summit

Drug Channels

Asembia’s Specialty Pharmacy Summit 2022. Asembia's Specialty Pharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialty pharmacy. Plus, Doug Long from IQVIA and I will again lead the Featured Session, titled The Specialty Pharmacy Industry Update and Outlook.

article thumbnail

Craig Holtgrave Joins Amber Specialty Pharmacy as Senior Vice President of Business Innovation

Amber

27, 2023) – Amber Specialty Pharmacy announces today that Craig Holtgrave has been named senior vice president of business innovation. Holtgrave joins Amber Specialty Pharmacy with more than 18 years of sales experience in the health care industry, with a strong focus in pharmaceutical manufacturing and pharmacy operations.

article thumbnail

Payor Considerations When Evaluating a Specialty Pharmacy Partner

Orsini Pharmacy

This includes a highly coordinated team and effort from multiple specialists, their care staff, the pharmaceutical manufacturer, the rare disease specialty pharmacy provider, and their patient support team. Almost 1 in 10 Americans are affected by a rare disease.

article thumbnail

Diagnosis to Treatment: Difficulties Rare Disease Patients Encounter

Orsini Pharmacy

Before any anticipated specialty drug launch, a pharmaceutical manufacturer conducts an extensive market access evaluation to determine the best distribution model for their specialty drug. In general, there are three distinct drug distribution models to consider for a specialty drug launch: open, limited, and exclusive.

article thumbnail

Navigating 340B Program Changes in 2025

Proxsys Rx

billion annually because of these restrictions, as drug companies limit 340B discounts on medications purchased through contract pharmacies. billion in 340B savings is at risk, due to increasing limitations imposed by pharmaceutical manufacturers which could further strain the healthcare safety net and patient care services.